PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.640
+0.010 (0.61%)
Nov 4, 2024, 4:00 PM EST - Market closed
PMV Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 84 | 159 | 397 | 1,048 | 2,754 | - | |
Market Cap Growth | -70.92% | -60.08% | -62.10% | -61.94% | - | - | |
Enterprise Value | -116 | -67 | 151 | 733 | 2,381 | - | |
Last Close Price | 1.63 | 3.10 | 8.70 | 23.10 | 61.51 | - | |
PE Ratio | - | -2.16 | -5.41 | -18.03 | -25.66 | - | |
PB Ratio | 0.39 | 0.70 | 1.61 | 3.40 | 7.67 | - | |
P/FCF Ratio | -1.80 | -2.80 | -5.54 | -21.88 | -83.74 | - | |
P/OCF Ratio | -1.83 | -2.85 | -6.23 | -22.51 | -84.12 | - | |
EV/EBITDA Ratio | 1.56 | 0.85 | -1.97 | -12.65 | -68.76 | - | |
EV/EBIT Ratio | 1.53 | 0.83 | -1.96 | -12.58 | -68.14 | - | |
EV/FCF Ratio | 2.52 | 1.18 | -2.10 | -15.30 | -72.40 | - | |
Debt / Equity Ratio | 0.06 | 0.06 | 0.06 | 0.04 | - | - | |
Debt / FCF Ratio | -0.28 | -0.23 | -0.19 | -0.23 | - | - | |
Quick Ratio | 18.70 | 14.47 | 22.25 | 24.32 | 56.38 | 22.44 | |
Current Ratio | 19.22 | 14.78 | 22.80 | 24.66 | 56.90 | 22.57 | |
Return on Equity (ROE) | -22.62% | -29.24% | -26.44% | -17.33% | -15.05% | -31.78% | |
Return on Assets (ROA) | -19.88% | -19.17% | -16.00% | -10.45% | -9.32% | -20.00% | |
Return on Capital (ROIC) | -20.82% | -20.07% | -16.61% | -10.73% | -9.55% | -20.87% | |
Earnings Yield | -58.21% | -43.48% | -18.45% | -5.52% | -1.25% | - | |
FCF Yield | -55.21% | -35.70% | -18.06% | -4.57% | -1.19% | - | |
Buyback Yield / Dilution | -11.19% | -5.31% | -1.01% | -214.23% | -373.26% | -0.76% | |
Total Shareholder Return | -11.19% | -5.31% | -1.01% | -214.23% | -373.26% | -0.76% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.